Keywords: Eli Lilly, Medical innovation, Policie,, Japan, USA, Biologicals data exclusivity, Price stability

Need for changes and policies that encourage medical innovation stressed by Lilly CEO at US/Japan meeting

Article | 10 March 2011

Print This

In remarks to the US/Japan Business Council yesterday in Tokyo Japan, John Lechleiter, chairman, president and chief executive of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in